Results 211 to 220 of about 19,263 (243)

Daratumumab in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials. [PDF]

Cancers (Basel)
Wang C, Xu Z, Jiang M, Chen Y, Lan Y.
europepmc   +1 more source

An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer’s Disease

Marc L. Gordon, Erica Christen, Lynda Keehlisen, Michelle N. Gong, Fung Lam, Luca Giliberto, Jesús J. Gomar, Jeremy Koppel   +7 more
openalex   +2 more sources

First Report of Daratumumab Therapy in Refractory THSD7A-Positive Membranous Nephropathy. [PDF]

Kidney Int Rep
Ribes D, Faguer S.
europepmc   +1 more source

Targeting Wnt/β-catenin signaling enhances the efficacy of anti-CD38 immunotherapy in multiple myeloma. [PDF]

Neoplasia
Li H, Chen Y, Gregorova M, Yang T, Zhang X, Yu X, Wang Z, Hua H, Ye L, Qi X, Spaargaren M, Pals ST, Ren Z.   +12 more
europepmc   +1 more source

A basic study to establish a new method to avoid the effects of daratumumab in indirect antiglobulin test

一平 登尾, 契太 木村, 沙希 中尾, 僚也 松形, 辰哉 川口, 行則 上妻   +5 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Daratumumab

Reactions Weekly
  +15 more sources

Daratumumab

Reactions Weekly, 2019
  +11 more sources